Mule Medical Reports H1 2021 Net Profit of RMB 8.6 Million, Up 141.46% Year-on-Year, Driven by Strong Revenue and Operating Profit Growth

Source: Wabei Network

WaBei.com, July 30: Mocular Medical (832652) recently released its 2021 semi-annual report. During the reporting period, the company recorded operating revenue of RMB 38,715,531.72, a year-on-year increase of 21.63%; net profit attributable to shareholders of the listed company was RMB 8,603,218.55, up 141.46% year-on-year.

Net cash flow from operating activities during the reporting period was -2,364,927.78 RMB, and net assets attributable to shareholders of the listed company at the end of the current period were 109,984,675.47 RMB.

Net profit for the current period amounted to RMB 8,376,595.28, representing a year-on-year increase of 143.82%. The reason is: the substantial increase in operating revenue and operating profit during the current period led to the increase in net profit.

The operating profit for the current period amounted to RMB 9,349,806.63, representing an increase of 171.01% compared to the same period last year. The reasons are as follows: the strong performance of the Company's new products during the current period, coupled with the sustained growth of existing products, drove a steady and continuous increase in operating revenue. Additionally, the VAT refunds received for software exceeding the tax burden threshold during the current period significantly boosted operating profit.

According to Wabei.com, Mocular Medical is a high-tech enterprise integrating ophthalmic big data cloud-based consultation and storage services, integrated medical information systems, and the R&D, manufacturing, sales, and services of digital ophthalmic equipment, providing users with optimal and high-quality visual health solutions.